Health
AABB Launches New Alliance to Support the U.S. Blood Supply
The Alliance for a Strong Blood Supply aims to improve the resilience of the blood supply.
As White House Voices Support for Rescheduling Marijuana, This Medical Cannabis Leader is Positioned for Growth
InterCure (NASDAQ: INCR), the leading medical cannabis player outside North America is ready to capitalize on the evolving regulatory environment.
CHOP Surgeons Separate Twin Girls Joined at the Chest and Abdomen
Addison and Lilianna Altobelli spent nearly a year at Children's Hospital of Philadelphia before being separated on October 13, 2021, and are now home in Chicago.
ChristianaCare Announces $500,000 in Scholarships for Students Pursuing Health Fields, in Partnership With HBCU Week Foundation
Scholarships designed to help diversify the workforce and improve health equity
Corpsmen, The Cutting Edge of U.S. Navy Medicine, Celebrates 126 Years
Photo caption: Rear Adm. Rick Freedman, Navy Deputy Surgeon General, and Force Master Chief PatrickPaul Mangaran, director of the Hospital Corps, pose with Sailors assigned to U.S. Navy Bureau of Medicine and Surgery headquarters before a commemorative command run for the 126th Hospital Corps birthday at the Defense Health Headquarters in Falls Church, Virginia, June 14. Sailors participated in the run, pausing at planned stops where they were educated on significant historical milestones of the Hospital Corps.
Devastating Tornadoes Activate National Blood Emergency Readiness Corps
Blood Emergency Readiness Corps responds with lifesaving blood products.
Dr. Ann Shippy’s Be Resilient Be Immune Program Provides Strategies to Build Immune Defenses and Lifelong Wellness
With all that's going on in the world, maintaining a strong immune system is more important than ever. Dr. Ann Shippy's Be Resilient Be Immune program provides the resources and strategies to help build immune defenses as well as lifelong wellness.
FDA Approves Besremi to Treat Adults With Polycythemia Vera
The FDA granted the approval of Besremi to PharmaEssentia Corporation
FDA Approves First Treatment for Common Type of Post-Transplant Infection That Is Resistant to Other Drugs
Approval is for cytomegalovirus, a type of herpes virus